Raymond James & Associates Uni Qure N.V. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$4.82 - $6.93 $119,810 - $172,259	-24,857 Reduced 47.6%	27,367 $142,000
Q4 2023 Jan 16, 2024	BUY	$5.63 - $8.27 $17,706 - $26,009	3,145 Added 6.41%	52,224 $353,000
Q3 2023 Oct 24, 2023	BUY	$6.71 - $11.83 $226,435 - $399,215	33,746 Added 220.09%	49,079 $329,000
Q2 2023 Jul 25, 2023	BUY	$11.12 - $22.2 $2,835 - $5,661	255 Added 1.69%	15,333 $175,000
Q1 2023 Apr 14, 2023	SELL	$18.7 - $23.07 $3,141 - $3,875	-168 Reduced 1.1%	15,078 $303,000
Q4 2022 Feb 08, 2023	SELL	$18.12 - $27.32 $4,457 - $6,720	-246 Reduced 1.59%	15,246 $345,000
Q3 2022 Oct 25, 2022	SELL	$16.98 - $25.54 $46,066 - $69,290	-2,713 Reduced 14.9%	15,492 $291,000
Q2 2022 Aug 12, 2022	SELL	$13.15 - $20.45 $74,599 - $116,012	-5,673 Reduced 23.76%	18,205 $339,000
Q1 2022 May 11, 2022	SELL	$14.54 - $21.5 $201,946 - $298,613	-13,889 Reduced 36.78%	23,878 $431,000
Q4 2021 Feb 08, 2022	SELL	$20.24 - $36.01 $122,553 - $218,040	-6,055 Reduced 13.82%	37,767 $783,000
Q3 2021 Nov 02, 2021	BUY	$26.01 - $38.22 $194,762 - $286,191	7,488 Added 20.61%	43,822 $1.4 Million
Q2 2021 Aug 11, 2021	BUY	$29.97 - $37.17 $842,606 - $1.05 Million	28,115 Added 342.07%	36,334 $1.12 Million
Q1 2021 May 14, 2021	BUY	$29.24 - $42.03 $240,323 - $345,444	8,219 New	8,219 $277,000
Q4 2020 Feb 12, 2021	SELL	$35.35 - $50.67 $393,728 - $564,362	-11,138 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$35.98 - $47.66 $165,364 - $219,045	4,596 Added 70.25%	11,138 $410,000
Q2 2020 Jul 28, 2020	BUY	$45.06 - $67.74 $43,573 - $65,504	967 Added 17.35%	6,542 $295,000
Q1 2020 Apr 21, 2020	SELL	$40.01 - $73.97 $37,489 - $69,309	-937 Reduced 14.39%	5,575 $265,000
Q4 2019 Feb 12, 2020	SELL	$37.13 - $74.62 $52,316 - $105,139	-1,409 Reduced 17.79%	6,512 $467,000
Q3 2019 Nov 07, 2019	BUY	$39.36 - $76.8 $311,770 - $608,332	7,921 New	7,921 $312,000

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account